Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
FDA reorganizes inspection staff; Thermo Fisher buys Patheon for $ 5.2 billion
This week in Phispers, read about the extortion cyberattack and how it impacted hospitals in the UK.
